FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Isoniazid Tablets
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

Teva Pharmaceuticals (New 10/27/2020)

Company Contact Information:

Presentation Posting Date Related Information
300 mg 1000 count (NDC 0555-0071-05) 10/27/2020 Teva made a business decision to discontinue the 1000 count presentation. The other presentations of Isoniazid Tablets product remain active.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English